CN112370415B - Quick-acting pore-shrinking composition and preparation method thereof - Google Patents
Quick-acting pore-shrinking composition and preparation method thereof Download PDFInfo
- Publication number
- CN112370415B CN112370415B CN202011331060.3A CN202011331060A CN112370415B CN 112370415 B CN112370415 B CN 112370415B CN 202011331060 A CN202011331060 A CN 202011331060A CN 112370415 B CN112370415 B CN 112370415B
- Authority
- CN
- China
- Prior art keywords
- composition
- phase
- stirring
- pore
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/405—Methods of mixing liquids with liquids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/43—Mixing liquids with liquids; Emulsifying using driven stirrers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a rapid pore-shrinking composition and a preparation method thereof, wherein the composition comprises an oil phase composition, a water phase composition and a pore-shrinking active composition, and the pore-shrinking active composition comprises the following components: soyamine, mandelic acid, gluconic acid, maltobionic acid, pyruvic acid, Shima Korea leaf/twig oil, and Mogata Stringylon leaf oil. The composition is prepared by compounding various natural fermentation raw materials and processing by an ultrahigh pressure nanocrystallization process. The active components of the rapid pore contraction composition are matched for use, so that the problem of large skin pores existing for a long time can be thoroughly solved, the rapid pore contraction composition is suitable for any skin type, the natural fermented fruit acid composite component is compounded, the old cutin is mildly and not stimulated to be rapidly metabolized, new skin cell energy is provided through other active components, a normal sebum secretion channel is repaired, and the original fineness and elasticity of the skin pores are recovered.
Description
Technical Field
The invention belongs to the technical field of skin care, and particularly relates to a quick-acting pore-shrinking composition and a preparation method thereof.
Background
More than twenty thousand pores on the facial skin can cause sebaceous glands to secrete grease when the temperature rises, the more the sebaceous glands secrete the grease, the more the grease is secreted, daily old waste cutin is easy to accumulate and thicken if not cleaned regularly, so that the pore outlet is blocked, the cutin, the sebum and dirt are gathered together at the pore grease secretion port, and bacteria are easy to breed after the cutin, the sebum and the dirt are cleaned properly, the pore walls are gradually propped and opened more and more, the phenomenon that the pores are large and large can be seen by naked eyes is generated, and the problem of inflammation and swelling acne is often caused.
Skin with vigorous grease secretion is always accompanied with the chance of pore blockage, sebum cannot be discharged completely through a pore channel, then solidified sebum forms white heads and blackheads, the interior of hair follicles is squeezed for a long time, pores are large, dry skin is lack of sufficient sebum moistening due to insufficient water retention of cuticle, desquamation is generated in serious conditions, and pores are insufficient in appearance fineness and are in a loose state.
The existing product for shrinking pores is not suitable for any skin, can not thoroughly solve the problem of large pores of skin for a long time, and some products can even cause irritation to the skin when in use.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention provides a rapid pore-shrinking composition and a preparation method and application thereof. The active components of the rapid pore contraction composition are matched for use, so that the problem of large skin pores existing for a long time can be thoroughly solved, the rapid pore contraction composition is suitable for any skin type, the complex natural fermented fruit acid complex component is utilized, the rapid metabolism of old cutin is mild and not stimulated, new skin cell energy is provided through other active components, and then a normal sebum secretion channel is repaired, so that the original fineness and elasticity of the skin pores are recovered.
The technical scheme adopted by the invention is as follows:
a fast acting pore-shrinking composition comprising an oil phase composition, an aqueous phase composition, and a pore-shrinking active composition, said pore-shrinking active composition comprising the following components: soyamine, mandelic acid, gluconic acid, maltobionic acid, pyruvic acid, leaf/twig oil of Pinus pumila (Pinus CEMBRA), leaf oil of Amomum melegueta (Aframomum ANGUSTIFOLIUM).
Preferably, the oil phase composition comprises the following components: hydrogenated lecithin, dioctyl carbonate, cyclopentadimethylsiloxane, polydimethylsiloxane, ceteareth-20.
Preferably, the composition of the aqueous phase comprises the following components: butanediol, propylene glycol, sodium hyaluronate, allantoin, poloxamer, EDTA disodium and deionized water.
Preferably, the pore-shrinking active composition is used in an amount of 7.50-10.20%.
Preferably, the composition consists of: 5.0 to 10.0 percent of butanediol, 4.0 to 8.0 percent of propanediol, 3.0 to 4.5 percent of hydrogenated lecithin, 3.0 to 4.0 percent of dioctyl carbonate, 3.0 to 4.0 percent of cyclopenta dimethyl silicone polymer, 2.0 to 3.0 percent of dimethyl silicone polymer, 202.0 to 2.5 percent of ceteareth-202, 2.0 to 2.5 percent of soybean amine, 1.5 to 2.0 percent of mandelic acid, 1.5 to 2.0 percent of gluconic acid, 1.3 to 1.8 percent of maltobionic acid, 1.0-1.5% of pyruvic acid, 1.0-1.5% of triethanolamine, 0.8-1.0% of poloxamer, 0.3-0.5% of sodium hyaluronate, 0.2-0.3% of allantoin, 0.2-0.3% of bacillus aceticus/saccharomycetes/apple fruit extract/lemon fruit extract/grape wine fermentation product filtrate, 0.1-0.2% of leaf/twig oil of Chinese litsea swiss, 0.1-0.2% of leaf oil of Amomum longiligulatum, 0.1-0.2% of disodium EDTA, 0.0001-0.1% of polyamine carbide nanoparticle solution, and the balance of deionized water.
Active substance soyamine
The soybean amine extracted from endogenous natural polyamine in soybean gradually reduces the content of polyamine in the body with the increase of age, so that the normal metabolic rate of skin cells is reduced, therefore, the supplementation of natural polyamine to restore the normal metabolic function of cells becomes very important, and the soybean amine supplementation has the effects of delaying skin aging, restoring skin vitality, promoting the proliferation of skin collagen and hyaluronic acid and effectively reducing the skin pore fineness.
The active ingredient, di-mandelic acid
Mandelic acid, also known as mandelic acid, is a lipophilic fruit acid that can accelerate the metabolism of old stratum corneum of skin, so that the new stratum corneum can improve the original dark skin color, reduce the original large pores, and restore the fineness of the pores.
Active tri-glucuronic acid
The gluconic acid is one of components existing in a human body, is obtained by fermentation of gluconobacter, is mild and non-irritant, can accelerate metabolism of old cuticle of the skin, improve the original dark complexion of the skin, reduce large pores, regulate excessive secretion of grease, and can assist the cuticle of the skin to recover the original barrier function and enhance the resistance to external pollution sources.
Active substance tetramaltobionic acid
The maltobionic acid fermented from the plant source has the moisturizing capability which is two times better than that of the existing lactobionic acid, metabolizes cutin to enable the skin to be smoother and finer, solves the problems of large pores, acne and the like, promotes the metabolism renewal of the skin, fades spots, increases the cleanliness of the pores, strengthens the function of the cutin barrier of the skin, enables the skin to be fuller and more compact and has elasticity, and improves wrinkles.
Active substance penta-pyruvic acid
The skin-care product is derived from glucose decomposition, is also called as pyroglutamic acid, has a molecular weight equivalent to that of the existing glycolic acid, is easy to absorb by the skin, has greatly reduced irritation compared with the skin pricking feeling caused by the existing glycolic acid, and has a considerable curative effect on acne, pox, large pores, conditioning oil secretion caused by abnormal oil secretion and treating keratosis symptoms.
Active substance of leaf/twig oil of Huishizhi stone pine (Pinus CEMBRA)
The lithopone oil is prepared by cold-pressing and extracting unique lithopone from Swiss, is commonly known as the Swiss pentaphyllum, mainly comprises natural polyphenol compounds with more than 30 main active ingredients, mainly comprises catechins, procyanidins, flavonoids, lignin and the like, the functions of all the polyphenols are different, the effects are mainly the concentrated antioxidant effect, the lithopone oil has the effects of calming the secretion of oil and lightening melanin spots on the face, further improving the original dark skin color of the skin and preventing the fine lines generated by the fracture of skin maternal collagen fiber cells under the irradiation of sunlight.
Active substance of leaf oil of Alpinia zerumbet (Aframomum ANGUSTIFOLIUM)
Is derived from African pepper, Capsici fructus, and oil of cardamomum leaf obtained by fractionation, is rich in various pinene (pinene) terpene elements, is used as natural antioxidant, has effects of activating cell energy, gradually improving facial fine lines, preventing facial skin free radical hyperplasia, and resisting bacteria.
Preferably, the pore-shrinking active composition is used in an amount of 8.8%.
Preferably, the composition consists of: 9.0% of butanediol, 7.0% of propylene glycol, 4.2% of hydrogenated lecithin, 4.0% of dioctyl carbonate, 4.0% of cyclopentadimethylsiloxane, 2.8% of polydimethylsiloxane, 202.2% of ceteareth-202, 2.1% of soya amine, 1.8% of mandelic acid, 2.0% of gluconic acid, 1.5% of maltonic acid, 1.2% of pyruvic acid, 1.4% of triethanolamine, 1.0% of poloxamer, 0.4% of sodium hyaluronate, 0.3% of allantoin, 0.3% of bacillus aceticus/microula malus extract/lemon fruit extract/wine fermentation product filtrate, 0.1% of Centrophora switzeri leaf/twig oil, 0.1% of Madajia leaf narrow leaf oil, 0.2% of disodium EDTA, 0.1% of a polyamine carbide solution nanoparticle, and the balance of deionized water.
The raw materials adopted by the invention are purchased from the market unless otherwise specified.
The invention also provides a preparation method of the rapid pore shrinking composition, which comprises the following steps:
(1) heating and stirring the oil phase composition until the oil phase composition is completely dispersed to serve as an A phase for later use;
(2) heating the water phase composition to 70-90 ℃ to completely dissolve the water phase composition to serve as a phase B for later use;
(3) dissolving mandelic acid, gluconic acid, maltobionic acid and pyruvic acid in the pore-shrinking active substance composition in deionized water at room temperature under stirring until no crystal particles exist, adding triethanolamine, adjusting the pH value to 3.5-4.5, and using the triethanolamine as a C phase for later use;
(4) pouring the phase A into the phase B, placing the phase B in a vacuum homogenizing and stirring pot, starting a stirring blade at the stirring speed of 500-1000 rpm, starting the homogenizing speed of 1000-3000 rpm, vacuumizing to 0.02-0.06 Mpa, after homogenizing and stirring for 10-25 mins, continuously vacuumizing, stirring and cooling to 30-55 ℃, after the vacuum pressure is released, sequentially adding the phase C, acetic acid bacillus/saccharomycetes/apple fruit extract/lemon fruit extract/grape wine fermentation product filtrate, soyamine, Swiss pinus sylvestris leaf/twig oil, Mojiasi katsumadai leaf oil and a carbonized polyamine nano particle solution, starting stirring at the stirring speed of 400-800 rpm, the homogenizing speed of 2000-4000 rpm, after homogenizing and stirring for 5-12 mins, continuously vacuumizing, stirring and cooling to 25-40 ℃, discharging a semi-finished product, filtering and barreling for later use;
(5) carrying out an ultrahigh pressure nano processing procedure, quantitatively adding the semi-finished product into a material inlet of a high-pressure homogenizer at a rate of 2-4 ml/sec by a peristaltic pump, starting a pressure control valve and a temperature control internal circulation machine, adding the material into the material inlet 3-5 times at a material pressure control range of 50-240 Mpa, and controlling the temperature of internal circulation of the material at 1-10 ℃; when the appearance of the material body is semitransparent, and the material body is conveyed, filtered and discharged through an external circulation rotor pump after the particle size is proper, so that the composition product with the rapid pore shrinkage can be obtained.
The ultrahigh pressure nanocrystallization process is to perform secondary homogenization on the inner material through a high pressure homogenizer to obtain a final finished product.
Preferably, after the treatment by the high-pressure homogenizer, the average high-pressure homogenized emulsified particle size is in the range of 30-100 nanometers.
The existing production is generally finished by a traditional high-speed homogenizing and dispersing emulsifying machine, the high-speed homogenizing and dispersing emulsifying machine is generally composed of a stainless steel rotor and a stator, and the emulsifying particle size can only reach a sub-nanometer grade and cannot form the grade of a nanometer emulsifying particle size. The apparatus is not effective in reducing the particle size of a rapid pore-shrinking composition product, nor is it effective in reducing the amount of active ingredient used.
The equipment adopted by the invention comprises two parts of high-speed homogenizing, dispersing and emulsifying and ultrahigh pressure nanometer processing, the invention utilizes an ultrahigh pressure nanometer processing program high pressure homogenizer to solve the problem of auxiliary equipment for reducing the emulsified particle size of the rapid-effect pore-shrinking composition for production, the equipment can be used for achieving the preset emulsified particle size, the particle size of the product can be reduced by the equipment as long as the viscosity of any type of final product is controlled below 2500cps, the requirement of the particle size is determined according to the homogenizing times and the adjusting pressure of the high pressure homogenizer repeatedly entering the ultrahigh pressure nanometer processing program, the homogenizing principle is that the emulsified material is subjected to the action of various turbulent impact forces, the high frequency vibration of air pockets generated by strong turbulent flow generates shearing force with the edge of a homogenizing valve and generates force with a homogenizing valve retaining ring, the processing of the nanometer particle size can be between 30 and 60 nanometers, and the effective components can rapidly permeate into the skin cuticle, the maximum effect is exerted, unlike the traditional emulsion which is not treated but has overlarge emulsion particle size and can only stay on the surface of the horny layer of the skin, the maximum effect of the active ingredients cannot be exerted, on the other hand, the high-pressure homogenizer can effectively reduce the dosage of the active ingredients by utilizing the ultrahigh-pressure nanometer processing procedure, thus the effects of reducing the dosage of the active ingredients and the traditional emulsified functional ingredients can be achieved, and the economic and efficient functions are achieved.
Preferably, the preparation method of the rapid pore-shrinking composition specifically comprises the following steps:
(1) heating, stirring and dispersing oil phase components of the inner material such as hydrogenated lecithin, dioctyl carbonate, cyclopenta dimethyl siloxane, dimethyl polysiloxane and ceteareth-20 to 75 ℃, and completely dispersing to obtain phase A for later use;
(2) heating water phase of the inner material to 80 deg.C for dissolving completely, and using as phase B;
(3) taking a proper amount of deionized water from mandelic acid, gluconic acid, maltonic acid and pyruvic acid in the pore-shrinking active substance composition of the inner material, stirring and dissolving at room temperature until no crystal particles exist, adding triethanolamine, adjusting the pH value to 3.8-4.0, and using the triethanolamine as a C phase for later use;
(4) pouring the phase A of the inner material into the phase B, placing the phase B in a fixed vacuum homogenizing and stirring pot, starting a fixed vacuumizing homogenizing and stirring blade, starting the stirring speed at 800rpm, starting the homogenizing speed at 2000rpm, vacuumizing to 0.04Mpa, after homogenizing and stirring for 15mins, continuously vacuumizing, stirring and cooling to 45 ℃, after the vacuum pressure is released, sequentially adding the phase C of the inner material, acetic acid bacillus/yeast/apple extract/lemon fruit extract/grape wine fermentation product filtrate, soyamine, Swiss pinus leaf/twig oil, Mogata katsumadai leaf oil and a carbonized polyamine nano particle solution, starting the stirring speed at 600rpm, homogenizing at 3000rpm, after homogenizing and stirring for 8mins, continuously vacuumizing, stirring and cooling to 35 ℃, and filtering and barreling a semi-finished product for later use;
(5) carrying out an ultrahigh pressure nano processing procedure on the inner material, quantitatively adding the semi-finished product into a material inlet of a high-pressure homogenizer at 3ml/sec by a peristaltic pump, starting a pressure control valve and a temperature control internal circulation machine, adding the material into the material inlet 3-5 times at a material pressure control range of 110Mpa, and controlling the temperature in material internal circulation at 3-5 ℃; and (3) when the appearance of the material body is semitransparent and the particle size is controlled to be 30-60 nanometers, conveying, filtering and discharging the material through an external circulation rotor pump to obtain the quick-acting pore-shrinking composition product.
The invention has the technical effects that:
(1) the active components of the rapid pore contraction composition are matched for use, so that the problem that skin pores are large for a long time can be thoroughly solved, the rapid pore contraction composition is suitable for any skin type, the complex natural fermented fruit acid complex component is utilized, the old cutin is mildly and not stimulated to be rapidly metabolized, new skin cell energy is provided through other active components, and then a normal sebum secretion channel is repaired, so that the original fineness and elasticity of the skin pores are recovered;
(2) the composition has the effects of conditioning oil secretion of pores, relieving acne wounds and quickly shrinking the pores, and has obvious effect on treating the symptom of large skin pores existing for a long time, and after the composition is used for smearing the large pores for 28 days for a long time, the previous large pore groups can almost completely and radically cure the symptom of abnormal oil secretion;
(3) the ultrahigh pressure nano processing procedure method converts the whole grain diameter of the essence into nano level, and the nano level composition can quickly permeate into the root part of the large pores to regulate the secretion of grease, so that the pores are contracted to normal state;
(4) the addition of the natural antibacterial agent in the carbonized polyamine nano particle solution replaces the traditional chemically synthesized preservative, has no irritation to pox wounds caused by abnormal secretion of skin pore grease, and in addition, the natural antibacterial agent has strong biodegradability and no pollution to the environment.
Detailed Description
The invention is further illustrated by the following examples, without limiting the scope of the invention.
Example 1
The inner material comprises butanediol 9.0kg, propylene glycol 7.0kg, hydrogenated lecithin 4.2kg, dioctyl carbonate 4.0kg, cyclopentadimethylsiloxane 4.0kg, polydimethylsiloxane 2.8kg, ceteareth-202.2 kg, soya amine 2.1kg, mandelic acid 1.8kg, gluconic acid 2.0kg, maltobionic acid 1.5kg, pyruvic acid 1.2kg, triethanolamine 1.4kg, poloxamer 1.0kg, sodium hyaluronate 0.4kg, allantoin 0.3kg, Acetobacter/yeast/Malus pumila extract/Citrus aurantium fruit extract/wine fermentation product filtrate 0.3kg, folium Lycopodii Pinus switzerlianus (PINUS CEMBRA) leaf/twig oil 0.1kg, Madajia narrow leaf cardamomum (Amomum nattifolium) leaf oil 0.1kg, disodium EDTA 0.2kg, carbonized polyamine nanoparticle solution 0.1kg, and deionized water 54.3 kg.
The preparation method of the rapid pore-shrinking composition specifically comprises the following steps:
(1) heating, stirring and dispersing oil phase components of the inner material such as hydrogenated lecithin, dioctyl carbonate, cyclopenta dimethyl siloxane, dimethyl polysiloxane and ceteareth-20 to 75 ℃, and completely dispersing to obtain phase A for later use;
(2) heating water phase of the inner material to 80 deg.C for dissolving completely, and using as phase B;
(3) taking a proper amount of deionized water from mandelic acid, gluconic acid, maltonic acid and pyruvic acid in the pore-shrinking active substance composition of the inner material, stirring and dissolving at room temperature until no crystal particles exist, adding triethanolamine, adjusting the pH value to 3.8-4.0, and using the triethanolamine as a C phase for later use;
(4) pouring the phase A of the inner material into the phase B, placing the phase B in a fixed vacuum homogenizing and stirring pot, starting a fixed vacuumizing homogenizing and stirring blade, starting the stirring speed at 800rpm, starting the homogenizing speed at 2000rpm, vacuumizing to 0.04Mpa, after homogenizing and stirring for 15mins, continuously vacuumizing, stirring and cooling to 45 ℃, after the vacuum pressure is released, sequentially adding the phase C of the inner material, acetic acid bacillus/yeast/apple fruit extract/lemon fruit extract/grape wine fermentation product filtrate, soyamine, rock pine swiss (PINUS CEMBRA) leaf/twig oil, Elaeagnus malabarius (AFRAMOMUM ANGTIFOLIUM) leaf oil and polyamine carbide nano particle solution, starting the stirring speed at 600rpm, the homogenizing speed at 3000rpm, after homogenizing and stirring for 8mins, continuously vacuumizing, stirring and cooling to 35 ℃, and filtering and barreling a semi-finished product for later use;
(5) carrying out an ultrahigh pressure nano processing procedure on the inner material, quantitatively adding the semi-finished product into a material inlet of a high-pressure homogenizer at 3ml/sec by a peristaltic pump, starting a pressure control valve and a temperature control internal circulation machine, adding the material into the material inlet 3-5 times at a material pressure control range of 110Mpa, and controlling the temperature in material internal circulation at 3-5 ℃; and (3) when the appearance of the material body is semitransparent and the particle size is controlled to be 30-60 nanometers, conveying, filtering and discharging the material through an external circulation rotor pump to obtain the quick-acting pore-shrinking composition product.
The skin pore shrinkage degree is judged by observing the change of relevant indexes of the skin pore size of a subject before and after the product is used, and the evaluation standard is as follows:
pore shrinkage reduction improvement: the pore size is basically not changed or enlarged without improvement or deterioration; slightly improved, the pores are still more obvious although being reduced; moderate improvement, and obvious pore reduction; obviously improving, obviously shrinking pores which are not very obvious;
vigorous lipid secretion improving property: the moderate degree is improved, and the secretion of grease is controlled obviously; obviously improved, the secretion of the grease is not very obvious;
relieving pox inflammation and pain: the moderate degree is improved, and the inflammation and pain of the pox are obviously relieved; obviously improve the inflammation and pain of the pox, and the inflammation and the pain are not very obvious;
skin moisturizing, spot-fading and improving properties: moderate improvement, obvious skin moisturizing and spot fading; obviously improve the skin, and the skin is not very obvious dry and has no spots.
In order to understand the using effect of the invention, extensive trial investigation is carried out on the product in the form of questionnaire, the questionnaire is totally incorporated into 1100 male and female testers all over the country, wherein, the male 385 and the female 715 are in the maximum age of 40, the minimum age of 18 and the average age of 28, and 930 effective questionnaires are totally collected.
The self-evaluation results of the 930 test subjects on the degree of each index related to the pore enlargement caused by abnormal oil secretion after using the quick-acting pore-shrinking composition for 28 days are as follows:
vigorous lipid secretion improving property: 85.6% and 92.1% of the subjects had moderate and significant improvement, respectively;
relieving pox inflammation and pain: moderate improvement and obvious improvement were found in 83.2% and 90.1% of the subjects, respectively;
skin moisturizing, spot-fading and improving properties: 89.6% and 94.3% of the subjects had moderate and significant improvement, respectively;
pore shrinkage reduction improvement: 92.7% and 97.2% of the subjects had moderate and significant improvement, respectively;
as can be seen from the results of the self-evaluation by the test subjects, the product has various degrees of significant improvements in the improvement of the oil secretion, the reduction of the pox inflammation and pain, the improvement of the skin moisturizing and spot fading, and the improvement of the reduction of the pore shrinkage.
And according to the survey results, displaying that: the rapid pore-shrinking composition disclosed by the invention is prepared by applying an optimal component proportion and matching with a high-pressure homogenizer to assist a nanocrystallization preparation method, and can well restore and recover the oil secretion of normal skin pores, reduce the phenomenon of large pores and restore the dense and compact state of the normal skin pores.
Example 2
The inner material comprises butanediol 10.0kg, propylene glycol 8.0kg, hydrogenated lecithin 4.5kg, dioctyl carbonate 4.0kg, cyclopentadimethylsiloxane 4.0kg, polydimethylsiloxane 3.0kg, ceteareth-202.5 kg, soya amine 2.5kg, mandelic acid 2.0kg, gluconic acid 2.0kg, maltobionic acid 1.8kg, pyruvic acid 1.5kg, triethanolamine 1.5kg, poloxamer 1.0kg, sodium hyaluronate 0.5kg, allantoin 0.3kg, Acetobacter/yeast/Malus pumila extract/Citrus aurantium fruit extract/wine fermentation product filtrate 0.25kg, folium Lycopodii Pinus switzerlianus (PINUS CEMBRA) leaf/twig oil 0.2kg, Madajia narrow leaf cardamomum (Amomum nattifolium) leaf oil 0.2kg, disodium EDTA 0.2kg, carbonized polyamine nanoparticle solution 0.1kg, and deionized water 50.05 kg.
The preparation method of the rapid pore-shrinking composition specifically comprises the following steps:
(1) heating, stirring and dispersing oil phase components of the inner material such as hydrogenated lecithin, dioctyl carbonate, cyclopenta dimethyl siloxane, dimethyl polysiloxane and ceteareth-20 to 75 ℃, and completely dispersing to obtain phase A for later use;
(2) heating water phase of the inner material to 80 deg.C for dissolving completely, and using as phase B;
(3) taking a proper amount of deionized water from mandelic acid, gluconic acid, maltonic acid and pyruvic acid in the pore-shrinking active substance composition of the inner material, stirring and dissolving at room temperature until no crystal particles exist, adding triethanolamine, adjusting the pH value to 3.8-4.0, and using the triethanolamine as a C phase for later use;
(4) pouring the phase A of the inner material into the phase B, placing the phase B in a fixed vacuum homogenizing and stirring pot, starting a fixed vacuumizing homogenizing and stirring blade, starting the stirring speed at 800rpm, starting the homogenizing speed at 2000rpm, vacuumizing to 0.04Mpa, after homogenizing and stirring for 15mins, continuously vacuumizing, stirring and cooling to 45 ℃, after the vacuum pressure is released, sequentially adding the phase C of the inner material, acetic acid bacillus/yeast/apple fruit extract/lemon fruit extract/grape wine fermentation product filtrate, soyamine, rock pine swiss (PINUS CEMBRA) leaf/twig oil, Elaeagnus malabarius (AFRAMOMUM ANGTIFOLIUM) leaf oil and polyamine carbide nano particle solution, starting the stirring speed at 600rpm, the homogenizing speed at 3000rpm, after homogenizing and stirring for 8mins, continuously vacuumizing, stirring and cooling to 35 ℃, and filtering and barreling a semi-finished product for later use;
(5) carrying out an ultrahigh pressure nano processing procedure on the inner material, quantitatively adding the semi-finished product into a material inlet of a high-pressure homogenizer at 3ml/sec by a peristaltic pump, starting a pressure control valve and a temperature control internal circulation machine, adding the material into the material inlet 3-5 times at a material pressure control range of 110Mpa, and controlling the temperature in material internal circulation at 3-5 ℃; and (3) when the appearance of the material body is semitransparent and the particle size is controlled to be 30-60 nanometers, conveying, filtering and discharging the material through an external circulation rotor pump to obtain the quick-acting pore-shrinking composition product.
In order to understand the using effect of the invention, extensive trial investigation is carried out on the product in the form of questionnaire, the questionnaire is totally incorporated into 1080 male and female testers all over the country, wherein 365 male and 715 female patients are 40 years old at the maximum, 18 years old at the minimum and 28 years old at the average, and 920 effective questionnaires are totally collected.
920 patients used the quick-acting pore-shrinking composition for 28 days, and then self-evaluated the degree of each index related to the pore enlargement caused by abnormal secretion of oil and fat as follows:
vigorous lipid secretion improving property: moderate improvement and obvious improvement were observed in 78.6% and 86.8% of subjects, respectively;
relieving pox inflammation and pain: moderate improvement and obvious improvement were found in 76.2% and 83.1% of the subjects, respectively;
skin moisturizing, spot-fading and improving properties: 79.6% and 89.1% of the subjects had moderate and significant improvement, respectively;
pore shrinkage reduction improvement: moderate improvement and obvious improvement were found in 87.1% and 93.7% of the subjects, respectively;
as can be seen from the results of the self-evaluation by the test subjects, the product has various degrees of significant improvements in the improvement of the oil secretion, the reduction of the pox inflammation and pain, the improvement of the skin moisturizing and spot fading, and the improvement of the reduction of the pore shrinkage.
Example 3
The inner material comprises butanediol 5.0kg, propylene glycol 4.0kg, hydrogenated lecithin 3.0kg, dioctyl carbonate 3.0kg, cyclopentadimethylsiloxane 3.0kg, polydimethylsiloxane 2.0kg, ceteareth-202.0 kg, soya amine 2.0kg, mandelic acid 1.5kg, gluconic acid 1.5kg, maltobionic acid 1.3kg, pyruvic acid 1.0kg, triethanolamine 1.0kg, poloxamer 0.8kg, sodium hyaluronate 0.3kg, allantoin 0.2kg, Acetobacter/yeast/Malus pumila fruit extract/Citrus aurantium fruit extract/wine fermentation product filtrate 0.2kg, folium Lycopodii (PINUS CEMBRA) leaf/twig oil 0.1kg, Madajia narrow leaf cardamom (RamomuaAFM ANTIFOLIUM) leaf oil 0.1kg, EDTA disodium 0.1kg, carbonized polyamine nanoparticle solution 0.9 kg, and deionized water 67.9 kg.
The preparation method of the rapid pore-shrinking composition specifically comprises the following steps:
(1) heating, stirring and dispersing oil phase components of the inner material such as hydrogenated lecithin, dioctyl carbonate, cyclopenta dimethyl siloxane, dimethyl polysiloxane and ceteareth-20 to 75 ℃, and completely dispersing to obtain phase A for later use;
(2) heating water phase of the inner material to 80 deg.C for dissolving completely, and using as phase B;
(3) taking a proper amount of deionized water from mandelic acid, gluconic acid, maltonic acid and pyruvic acid in the pore-shrinking active substance composition of the inner material, stirring and dissolving at room temperature until no crystal particles exist, adding triethanolamine, adjusting the pH value to 3.8-4.0, and using the triethanolamine as a C phase for later use;
(4) pouring the phase A of the inner material into the phase B, placing the phase B in a fixed vacuum homogenizing and stirring pot, starting a fixed vacuumizing homogenizing and stirring blade, starting the stirring speed at 800rpm, starting the homogenizing speed at 2000rpm, vacuumizing to 0.04Mpa, after homogenizing and stirring for 15mins, continuously vacuumizing, stirring and cooling to 45 ℃, after the vacuum pressure is released, sequentially adding the phase C of the inner material, acetic acid bacillus/yeast/apple fruit extract/lemon fruit extract/grape wine fermentation product filtrate, soyamine, rock pine swiss (PINUS CEMBRA) leaf/twig oil, Elaeagnus malabarius (AFRAMOMUM ANGTIFOLIUM) leaf oil and polyamine carbide nano particle solution, starting the stirring speed at 600rpm, the homogenizing speed at 3000rpm, after homogenizing and stirring for 8mins, continuously vacuumizing, stirring and cooling to 35 ℃, and filtering and barreling a semi-finished product for later use;
(5) carrying out an ultrahigh pressure nano processing procedure on the inner material, quantitatively adding the semi-finished product into a material inlet of a high-pressure homogenizer at 3ml/sec by a peristaltic pump, starting a pressure control valve and a temperature control internal circulation machine, adding the material into the material inlet 3-5 times at a material pressure control range of 110Mpa, and controlling the temperature in material internal circulation at 3-5 ℃; and (3) when the appearance of the material body is semitransparent and the particle size is controlled to be 30-60 nanometers, conveying, filtering and discharging the material through an external circulation rotor pump to obtain the quick-acting pore-shrinking composition product.
In order to understand the using effect of the invention, extensive trial investigation is carried out on the product in the form of questionnaire, the questionnaire is totally incorporated into 1080 male and female testers all over the country, wherein 365 male and 715 female patients are 42 years old at the maximum, 16 years old at the minimum and 28 years old at the average, and 920 effective questionnaires are totally collected.
920 patients used the quick-acting pore-shrinking composition for 28 days, and then self-evaluated the degree of each index related to the pore enlargement caused by abnormal secretion of oil and fat as follows:
vigorous lipid secretion improving property: moderate improvement and obvious improvement were observed in 74.6% and 80.9% of subjects, respectively;
relieving pox inflammation and pain: moderate improvement and obvious improvement were found in 72.4% and 79.6% of subjects, respectively;
skin moisturizing, spot-fading and improving properties: 75.6% and 83.3% of the subjects had moderate and significant improvement, respectively;
pore shrinkage reduction improvement: 80.1% and 85.9% of the subjects had moderate and significant improvement, respectively;
as can be seen from the results of the self-evaluation by the test subjects, the product has various degrees of significant improvements in the improvement of the oil secretion, the reduction of the pox inflammation and pain, the improvement of the skin moisturizing and spot fading, and the improvement of the reduction of the pore shrinkage.
Example 4
The inner material comprises butanediol 9.0kg, propylene glycol 7.0kg, hydrogenated lecithin 4.2kg, dioctyl carbonate 4.0kg, cyclopentadimethylsiloxane 4.0kg, polydimethylsiloxane 2.8kg, ceteareth-202.2 kg, soya amine 2.1kg, mandelic acid 1.8kg, gluconic acid 2.0kg, maltobionic acid 1.5kg, pyruvic acid 1.2kg, triethanolamine 1.4kg, poloxamer 1.0kg, sodium hyaluronate 0.4kg, allantoin 0.3kg, Acetobacter/yeast/Malus pumila extract/Citrus aurantium fruit extract/wine fermentation product filtrate 0.3kg, folium Lycopodii Pinus switzerlianus (PINUS CEMBRA) leaf/twig oil 0.1kg, Madajia narrow leaf cardamomum (Amomum nattifolium) leaf oil 0.1kg, disodium EDTA 0.2kg, carbonized polyamine nanoparticle solution 0.1kg, and deionized water 54.3 kg.
The preparation method of the rapid pore-shrinking composition specifically comprises the following steps:
(1) heating, stirring and dispersing oil phase components of the inner material such as hydrogenated lecithin, dioctyl carbonate, cyclopenta dimethyl siloxane, dimethyl polysiloxane and ceteareth-20 to 70 ℃ for complete dispersion, and taking the mixture as phase A for later use;
(2) heating water phase of the inner material to 75 deg.C for dissolving completely, and using as phase B;
(3) taking a proper amount of deionized water from mandelic acid, gluconic acid, maltonic acid and pyruvic acid in the pore-shrinking active substance composition of the inner material, stirring and dissolving at room temperature until no crystal particles exist, adding triethanolamine, adjusting the pH value to 3.8-4.0, and using the triethanolamine as a C phase for later use;
(4) pouring the phase A of the inner material into the phase B, placing the phase B in a fixed vacuum homogenizing and stirring pot, starting a fixed vacuumizing homogenizing and stirring blade, stirring at the speed of 600rpm, starting the homogenizing and stirring at the speed of 1500rpm, vacuumizing to 0.03Mpa, after homogenizing and stirring for 15mins, continuously vacuumizing, stirring and cooling to 40 ℃, after the vacuum pressure is released, sequentially adding the phase C of the inner material, acetic acid bacteria/yeast/apple fruit extract/lemon fruit extract/grape wine fermentation product filtrate, soyamine, rock pine swiss (PINUS CEMBRA) leaf/twig oil, Elaeagnus malaccensis (AFRAMOMUM ANGTIFOLIUM) leaf oil and polyamine carbide nano particle solution, starting the stirring speed of 700rpm, the homogenizing speed of 2500rpm, after homogenizing and stirring for 8mins, continuously vacuumizing, stirring and cooling to 30 ℃, and filtering and barreling a semi-finished product for later use;
(5) carrying out an ultrahigh pressure nano processing procedure on the inner material, quantitatively adding the semi-finished product into a material inlet of a high-pressure homogenizer at 2ml/sec by a peristaltic pump, starting a pressure control valve and a temperature control internal circulation machine, adding the material into the material inlet 3-5 times at a material pressure control range of 150Mpa, and controlling the temperature in material internal circulation at 5-7 ℃; and (3) when the appearance of the material body is semitransparent and the particle size is controlled to be 30-60 nanometers, conveying, filtering and discharging the material through an external circulation rotor pump to obtain the quick-acting pore-shrinking composition product.
In order to understand the using effect of the invention, extensive trial investigation is carried out on the product in the form of questionnaire, the questionnaire is totally incorporated into 1000 male and female testers all over the country, wherein 380 male testers and 720 female testers are aged at the maximum of 42 years, the minimum of 18 years and the average age is about 29 years, and 900 effective questionnaires are collected.
The self-evaluation results of the 930 test subjects on the degree of each index related to the pore enlargement caused by abnormal oil secretion after using the quick-acting pore-shrinking composition for 28 days are as follows:
vigorous lipid secretion improving property: moderate improvement and obvious improvement were found in 76.7% and 82.4% of subjects, respectively;
relieving pox inflammation and pain: moderate improvement and obvious improvement were found in 73.6% and 80.3% of the subjects, respectively;
skin moisturizing, spot-fading and improving properties: moderate improvement and obvious improvement were found in 79.2% and 84.3% of subjects, respectively;
pore shrinkage reduction improvement: moderate improvement and obvious improvement were found in 82.7% and 87.6% of subjects, respectively;
as can be seen from the results of the self-evaluation by the test subjects, the product has various degrees of significant improvements in the improvement of the oil secretion, the reduction of the pox inflammation and pain, the improvement of the skin moisturizing and spot fading, and the improvement of the reduction of the pore shrinkage.
It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the concept of the present application, which falls within the scope of protection of the present application.
Claims (4)
1. A rapid pore shrinking composition characterized by: the composition comprises an oil phase composition, a water phase composition and a pore-shrinking active composition, wherein the oil phase composition comprises the following components: hydrogenated lecithin, dioctyl carbonate, cyclopentadimethylsiloxane, polydimethylsiloxane, ceteareth-20; the composition of the water phase comprises the following components: butanediol, propylene glycol, sodium hyaluronate, allantoin, poloxamer, EDTA disodium and deionized water; the pore-shrinking active composition comprises the following components: soyamine, mandelic acid, gluconic acid, maltobionic acid, pyruvic acid, Centrophora switzerland leaf/twig oil, and Malatka cardamon leaf oil; the composition comprises the following components in percentage by mass: 5.0 to 10.0 percent of butanediol, 4.0 to 8.0 percent of propanediol, 3.0 to 4.5 percent of hydrogenated lecithin, 3.0 to 4.0 percent of dioctyl carbonate, 3.0 to 4.0 percent of cyclopenta dimethyl silicone polymer, 2.0 to 3.0 percent of dimethyl silicone polymer, 202.0 to 2.5 percent of ceteareth-202, 2.0 to 2.5 percent of soybean amine, 1.5 to 2.0 percent of mandelic acid, 1.5 to 2.0 percent of gluconic acid, 1.3 to 1.8 percent of maltobionic acid, 1.0-1.5% of pyruvic acid, 1.0-1.5% of triethanolamine, 0.8-1.0% of poloxamer, 0.3-0.5% of sodium hyaluronate, 0.2-0.3% of allantoin, 0.2-0.3% of bacillus aceticus/saccharomycetes/apple fruit extract/lemon fruit extract/grape wine fermentation product filtrate, 0.1-0.2% of leaf/twig oil of Chinese litsea swiss, 0.1-0.2% of leaf oil of Amomum longiligulatum, 0.1-0.2% of disodium EDTA, 0.0001-0.1% of polyamine carbide nanoparticle solution, and the balance of deionized water;
the composition is prepared by the following method:
(1) heating and stirring the oil phase composition until the oil phase composition is completely dispersed to serve as an A phase for later use;
(2) heating the water phase composition to 70-90 ℃ to completely dissolve the water phase composition to serve as a phase B for later use;
(3) dissolving mandelic acid, gluconic acid, maltobionic acid and pyruvic acid in the pore-shrinking active substance composition in deionized water at room temperature under stirring until no crystal particles exist, adding triethanolamine, adjusting the pH value to 3.5-4.5, and using the triethanolamine as a C phase for later use;
(4) pouring the phase A into the phase B, placing the phase B in a vacuum homogenizing and stirring pot, starting a stirring blade at the stirring speed of 500-1000 rpm, starting the homogenizing speed of 1000-3000 rpm, vacuumizing to 0.02-0.06 Mpa, after homogenizing and stirring for 10-25 mins, continuously vacuumizing, stirring and cooling to 30-55 ℃, after the vacuum pressure is released, sequentially adding the phase C, acetic acid bacillus/saccharomycetes/apple fruit extract/lemon fruit extract/grape wine fermentation product filtrate, soyamine, Swiss pinus sylvestris leaf/twig oil, Mojiasi katsumadai leaf oil and a carbonized polyamine nano particle solution, starting stirring at the stirring speed of 400-800 rpm, the homogenizing speed of 2000-4000 rpm, after homogenizing and stirring for 5-12 mins, continuously vacuumizing, stirring and cooling to 25-40 ℃, discharging a semi-finished product, filtering and barreling for later use;
(5) carrying out an ultrahigh pressure nano processing procedure, quantitatively adding the semi-finished product into a material inlet of a high-pressure homogenizer at a rate of 2-4 ml/sec by a peristaltic pump, starting a pressure control valve and a temperature control internal circulation machine, adding the material into the material inlet 3-5 times at a material pressure control range of 50-240 Mpa, and controlling the temperature of internal circulation of the material at 1-10 ℃; and (3) when the appearance of the material body is semitransparent, and after the particle size is controlled to be 30-100 nanometers, the material body is conveyed, filtered and discharged through an external circulation rotor pump, so that the quick-acting pore-shrinking composition product is obtained.
2. The fast acting pore-shrinking composition according to claim 1, wherein: the usage amount of the pore-shrinking active substance is 8.8%.
3. The fast-acting pore-shrinking composition according to claim 2, characterized in that said composition consists of: 9.0% of butanediol, 7.0% of propylene glycol, 4.2% of hydrogenated lecithin, 4.0% of dioctyl carbonate, 4.0% of cyclopentadimethylsiloxane, 2.8% of polydimethylsiloxane, 202.2% of ceteareth-202, 2.1% of soya amine, 1.8% of mandelic acid, 2.0% of gluconic acid, 1.5% of maltonic acid, 1.2% of pyruvic acid, 1.4% of triethanolamine, 1.0% of poloxamer, 0.4% of sodium hyaluronate, 0.3% of allantoin, 0.3% of bacillus aceticus/microula malus extract/lemon fruit extract/wine fermentation product filtrate, 0.1% of Centrophora switzeri leaf/twig oil, 0.1% of Madajia leaf narrow leaf oil, 0.2% of disodium EDTA, 0.1% of a polyamine carbide solution nanoparticle, and the balance of deionized water.
4. The rapid pore-shrinking composition according to claim 1, wherein said composition is prepared by a method comprising:
(1) heating, stirring and dispersing oil phase components of the inner material such as hydrogenated lecithin, dioctyl carbonate, cyclopenta dimethyl siloxane, dimethyl polysiloxane and ceteareth-20 to 75 ℃, and completely dispersing to obtain phase A for later use;
(2) heating water phase of the inner material to 80 deg.C for dissolving completely, and using as phase B;
(3) taking a proper amount of deionized water from mandelic acid, gluconic acid, maltonic acid and pyruvic acid in the pore-shrinking active substance composition of the inner material, stirring and dissolving at room temperature until no crystal particles exist, adding triethanolamine, adjusting the pH value to 3.8-4.0, and using the triethanolamine as a C phase for later use;
(4) pouring the phase A of the inner material into the phase B, placing the phase B in a fixed vacuum homogenizing and stirring pot, starting a fixed vacuumizing homogenizing and stirring blade, starting the stirring speed at 800rpm, starting the homogenizing speed at 2000rpm, vacuumizing to 0.04Mpa, after homogenizing and stirring for 15mins, continuously vacuumizing, stirring and cooling to 45 ℃, after the vacuum pressure is released, sequentially adding the phase C of the inner material, acetic acid bacillus/yeast/apple extract/lemon fruit extract/grape wine fermentation product filtrate, soyamine, Swiss pinus leaf/twig oil, Mogata katsumadai leaf oil and a carbonized polyamine nano particle solution, starting the stirring speed at 600rpm, homogenizing at 3000rpm, after homogenizing and stirring for 8mins, continuously vacuumizing, stirring and cooling to 35 ℃, and filtering and barreling a semi-finished product for later use;
(5) carrying out an ultrahigh pressure nano processing procedure on the inner material, quantitatively adding the semi-finished product into a material inlet of a high-pressure homogenizer at 3ml/sec by a peristaltic pump, starting a pressure control valve and a temperature control internal circulation machine, adding the material into the material inlet 3-5 times at a material pressure control range of 110Mpa, and controlling the temperature in material internal circulation at 3-5 ℃; and (3) when the appearance of the material body is semitransparent and the particle size is controlled to be 30-60 nanometers, conveying, filtering and discharging the material through an external circulation rotor pump to obtain the quick-acting pore-shrinking composition product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011331060.3A CN112370415B (en) | 2020-11-24 | 2020-11-24 | Quick-acting pore-shrinking composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011331060.3A CN112370415B (en) | 2020-11-24 | 2020-11-24 | Quick-acting pore-shrinking composition and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112370415A CN112370415A (en) | 2021-02-19 |
CN112370415B true CN112370415B (en) | 2022-04-22 |
Family
ID=74587921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011331060.3A Active CN112370415B (en) | 2020-11-24 | 2020-11-24 | Quick-acting pore-shrinking composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112370415B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114028245B (en) * | 2021-11-29 | 2024-03-26 | 浙江宜格企业管理集团有限公司 | Mild exfoliating composition and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105012184A (en) * | 2015-07-29 | 2015-11-04 | 杭州香硕生物科技有限公司 | Cosmetic composition for regulating cutin skin |
CN105168027A (en) * | 2015-08-14 | 2015-12-23 | 百芮生物科技(上海)有限公司 | Essence added with natural anti-allergy repair combination and preparation method of essence |
WO2016007601A1 (en) * | 2014-07-11 | 2016-01-14 | Mary Kay Inc. | Pore minimizer |
CA3063540A1 (en) * | 2017-05-22 | 2018-11-29 | Dermala Inc. | Compositions and methods for preventing, slowing, and reversing skin aging |
CN109846740A (en) * | 2019-01-30 | 2019-06-07 | 江苏长泰药业有限公司 | Skin care compositions and methods and its preparation method and application |
CN110893149A (en) * | 2019-12-30 | 2020-03-20 | 盛芮医疗科技(杭州)有限公司 | Composition added with natural antibacterial repair components, preparation method and application thereof |
-
2020
- 2020-11-24 CN CN202011331060.3A patent/CN112370415B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016007601A1 (en) * | 2014-07-11 | 2016-01-14 | Mary Kay Inc. | Pore minimizer |
CN105012184A (en) * | 2015-07-29 | 2015-11-04 | 杭州香硕生物科技有限公司 | Cosmetic composition for regulating cutin skin |
CN105168027A (en) * | 2015-08-14 | 2015-12-23 | 百芮生物科技(上海)有限公司 | Essence added with natural anti-allergy repair combination and preparation method of essence |
CA3063540A1 (en) * | 2017-05-22 | 2018-11-29 | Dermala Inc. | Compositions and methods for preventing, slowing, and reversing skin aging |
CN109846740A (en) * | 2019-01-30 | 2019-06-07 | 江苏长泰药业有限公司 | Skin care compositions and methods and its preparation method and application |
CN110893149A (en) * | 2019-12-30 | 2020-03-20 | 盛芮医疗科技(杭州)有限公司 | Composition added with natural antibacterial repair components, preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112370415A (en) | 2021-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110693756A (en) | Deep moisturizing composition and application thereof, and deep moisturizing mask | |
CN103191042A (en) | Skin care agent capable of removing freckles, whitening, preventing wrinkles, moisturizing and resisting allergy and ageing | |
CN111166683A (en) | Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof | |
CN113786376B (en) | Eye cream composition with eye pattern removing effect and preparation method thereof | |
CN110893149B (en) | Composition added with natural antibacterial repair components, preparation method and application thereof | |
CN102113987A (en) | Cosmetic containing natural plant extractives and preparation method thereof | |
CN107281020A (en) | A kind of preparation method of maca whitening and skin-protecting emulsion | |
CN110693780A (en) | Skin nourishing composition and application thereof, and skin nourishing mask liquid | |
CN108158885A (en) | Repair composition of striae of pregnancy and its preparation method and application | |
CN112006958A (en) | Depilatory cream and preparation method thereof | |
CN112370415B (en) | Quick-acting pore-shrinking composition and preparation method thereof | |
CN106333880B (en) | toner based on thin emulsion and preparation method thereof | |
CN113730272B (en) | Eye-protecting patch with eye fatigue relieving effect and preparation method thereof | |
CN106074190B (en) | A kind of anti-aging visage block cream and preparation method thereof | |
CN109662936A (en) | Antipruritic toner of antiallergic anti-pruritic compositions, antiallergic and its preparation method and application | |
CN109875941B (en) | Nursing mask and preparation method thereof | |
CN112076104A (en) | Composition with skin repairing function | |
CN111821230A (en) | Anti-allergy repairing cosmetic composition and application thereof | |
CN115154343B (en) | Composition and preparation for improving eye relaxation and black eye, preparation method and application | |
CN108261379B (en) | Facial mask and preparation method thereof | |
CN105919886A (en) | Quick-acting wrinkle repairing emulsion and preparation method thereof | |
KR102305154B1 (en) | Cosmetic compositions for increasing the density and the length of eyebrows or eyelashes | |
WO2016195141A1 (en) | Method for producing natural cosmetic liquid soap | |
CN110559240A (en) | whitening and anti-aging mask and preparation method thereof | |
CN111789800A (en) | Aloe composite repair factor and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |